| Disordered microbial communities in asthmatic airways M Hilty, C Burke, H Pedro, P Cardenas, A Bush, C Bossley, J Davies, ... PloS one 5 (1), e8578, 2010 | 1812 | 2010 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 508 | 2022 |
| SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant Y Konno, I Kimura, K Uriu, M Fukushi, T Irie, Y Koyanagi, D Sauter, ... Cell reports 32 (12), 2020 | 387 | 2020 |
| Airway microbiota in severe asthma and relationship to asthma severity and phenotypes Q Zhang, M Cox, Z Liang, F Brinkmann, PA Cardenas, R Duff, P Bhavsar, ... PloS one 11 (4), e0152724, 2016 | 160 | 2016 |
| COVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America. B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Marquez, B Gutierrez, ... | 124 | 2020 |
| Upper airways microbiota in antibiotic-naive wheezing and healthy infants from the tropics of rural Ecuador PA Cardenas, PJ Cooper, MJ Cox, M Chico, C Arias, MF Moffatt, ... Public Library of Science 7 (10), e46803, 2012 | 102 | 2012 |
| A case of SARS-CoV-2 reinfection in Ecuador B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Márquez, B Gutierrez, ... The Lancet Infectious Diseases 21 (6), e142, 2021 | 95 | 2021 |
| Investigation of an outbreak of central venous catheter–associated bloodstream infection due to contaminated water RW Douce, J Zurita, O Sanchez, PC Aldaz Infection Control & Hospital Epidemiology 29 (4), 364-366, 2008 | 47 | 2008 |
| Diverse commensal Escherichia coli clones and plasmids disseminate antimicrobial resistance genes in domestic animals and children in a semirural community in Ecuador L Salinas, P Cárdenas, TJ Johnson, K Vasco, J Graham, G Trueba Msphere 4 (3), e00316-19, 2019 | 44 | 2019 |
| Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome PA Cárdenas, D Garcés, B Prado-Vivar, N Flores, M Fornasini, H Cohen, ... European Journal of Clinical Microbiology & Infectious Diseases 39, 1365-1372, 2020 | 43 | 2020 |
| Analysis of gut microbiome, nutrition and immune status in autism spectrum disorder: a case-control study in Ecuador MF Zurita, PA Cárdenas, ME Sandoval, MC Peña, M Fornasini, N Flores, ... Gut Microbes 11 (3), 453-464, 2020 | 39 | 2020 |
| Environmental Spread of Extended Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli and ESBL Genes among Children and Domestic Animals in … L Salinas, F Loayza, P Cárdenas, C Saraiva, TJ Johnson, H Amato, ... Environmental health perspectives 129 (2), 027007, 2021 | 28 | 2021 |
| Mobile genetic elements associated with carbapenemase genes in South American Enterobacterales JA Reyes, R Melano, PA Cárdenas, G Trueba Brazilian Journal of Infectious Diseases 24, 231-238, 2020 | 25 | 2020 |
| Molecular Identification of Leishmania spp. in Sand Flies (Diptera: Psychodidae, Phlebotominae) From Ecuador C Quiroga, V Cevallos, D Morales, ME Baldeón, P Cárdenas, ... Journal of medical entomology 54 (6), 1704-1711, 2017 | 21 | 2017 |
| Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador B Gutierrez, S Márquez, B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, ... medRxiv, 2021 | 15 | 2021 |
| Changes in dominant Escherichia coli and antimicrobial resistance after 24 hr in fecal matter S Barrera, P Cardenas, JP Graham, G Trueba Microbiologyopen 8 (2), e00643, 2019 | 15 | 2019 |
| Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador S Márquez, B Prado-Vivar, JJ Guadalupe, B Gutierrez, M Jibaja, M Tobar, ... MedRxiv, 2020 | 14 | 2020 |
| Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection K Uriu, P Cárdenas, E Muñoz, V Barragan, Y Kosugi, K Shirakawa, ... The Journal of Infectious Diseases 226 (7), 1200-1203, 2022 | 13 | 2022 |
| SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep 32: 108185 Y Konno, I Kimura, K Uriu, M Fukushi, T Irie, Y Koyanagi, D Sauter, ... | 12 | 2020 |
| Molecular typing of a large nosocomial outbreak of KPC-producing bacteria in the biggest tertiary-care hospital of Quito, Ecuador MB Prado-Vivar, L Ortiz, J Reyes, E Villacis, M Fornasini, ME Baldeon, ... Journal of global antimicrobial resistance 19, 328-332, 2019 | 12 | 2019 |
Gabriel TruebaUniversidad San Francisco de Quito, EcuadorVerified email at usfq.edu.ec
